CYRX Cash Flow Breakdown | CRYOPORT, INC.

CRYOPORT, INC. Cash Flow Breakdown

Cash flow breakdown shows where CRYOPORT, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

Fiscal year ended 2026-03-31: from running the business, $503.00K went out.
Fiscal year ended 2026-03-31: from investing, $263.12M came in.
Fiscal year ended 2026-03-31: from financing, $20.80M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year end	Running the business	From investing	Buybacks	Debt paid back	Commercial paper	New shares sold	Not split out	Change in cash
2026-03-31	-$503.00K*	$263.12M*				$4.20M*	-$25.00M*
2025-12-31	-$8.58M	$250.32M	-$10.01M			$3.97M	-$15.04M*	$205.21M
2025-03-31	-$17.40M*	$176.29M*				$2.17M*	-$164.41M*
2024-12-31	-$16.32M	$176.81M		-$163.77M		$2.79M	-$549.00K*	-$1.06M
2024-03-31	-$6.80M*	$43.87M*				$2.00M*	-$25.36M*
2023-12-31	-$757.00K	$36.05M		-$25.00M		$1.48M		$9.75M
2023-03-31	$399.00K*	-$64.11M*					-$31.05M*
2022-12-31	-$1.85M	-$59.68M	-$37.96M				-$1.21M*	-$102.51M
2022-03-31	$14.64M*	-$250.83M*					$284.90M*
2021-12-31	$8.13M	-$469.25M	$0.00			$0.00	$564.34M*	$102.23M
2021-03-31	-$21.92M*	-$597.14M*					$654.11M*
2020-12-31	-$14.87M	-$382.31M	$0.00			$28.16M	$357.43M*	-$10.36M
2020-03-31	-$75.40K*	-$57.82M*					$75.72M*
2019-12-31	-$1.32M	-$62.93M				$0.00	$74.15M*	$9.91M
2019-03-31	-$2.48M*	-$18.25M*					$34.52M*	$13.78M*
2018-12-31	-$3.35M	-$12.88M				$9.81M	$28.72M*	$22.28M
2018-03-31	-$3.82M*	-$1.44M*				-$11.57M*	$21.29M*	$4.46M*
2017-12-31	-$3.58M	-$1.80M				$0.00	$15.90M*	$10.52M
2017-03-31	-$4.57M*	-$1.30M*				$11.57M*	$6.05M*
2016-12-31	-$5.72M	-$1.07M				$0.00	$6.06M*	-$722.90K
2016-03-31	-$6.31M	-$1.12M				$5.94M	$2.87M*
2015-12-31	-$5.63M*	-$716.27K*				$10.94M*
2015-03-31	-$4.13M	-$70.13K				$0.00	$5.23M*
2014-12-31	-$4.06M*	-$67.20K*					$4.68M*
2014-03-31	-$4.38M	-$138.89K					$4.33M*	-$193.52K
2013-12-31	-$4.27M*	-$247.06K*					$4.15M*	-$365.14K*
2013-03-31	-$4.79M	-$178.68K			$0.00	$0.00	$909.39K*	-$4.05M
2012-12-31	-$5.78M*	-$90.16K*					$3.66M*	-$2.21M*
2012-03-31	-$6.78M	-$388.06K			-$90.00K	$4.72M	-$2.12M*	-$4.66M
2011-12-31	-$5.85M*	-$439.97K*					$6.37M*	$85.11K*
2011-03-31	-$4.81M	-$465.45K				$11.57M	-$645.87K*	$5.65M

Each quarter (3 month)

Quarter end	Running the business	From investing	Buybacks	Debt paid back	Commercial paper	New shares sold	Not split out	Change in cash
2026-06-30	$1.13M*	-$5.81M*				$801.00K*
2026-03-31	$3.73M	$18.72M				$229.00K		$22.42M
2025-12-31	$919.00K*	$56.00K*	-$2.01M*			-$1.00K*
2025-09-30	$2.19M*	$14.31M*	-$3.75M*			$1.02M*
2025-06-30	-$7.34M*	$230.04M*				$2.95M*	-$18.81M*
2025-03-31	-$4.34M	$5.92M				$3.00K		$2.07M
2024-12-31	-$5.48M*	$3.48M*		$0.00*		$2.14M*
2024-09-30	$447.00K*	$153.57M*		-$155.11M*		$21.00K*
2024-06-30	-$8.03M*	$13.32M*				$9.00K*	-$8.77M*
2024-03-31	-$3.27M	$6.45M				$618.00K		$3.32M
2023-12-31	$2.48M*	-$14.76M*		$0.00*		-$2.00K*
2023-09-30	-$1.96M*	$18.51M*				$180.00K*	-$25.07M*
2023-06-30	-$4.05M*	$33.68M*				$1.21M*
2023-03-31	$2.77M	-$1.38M				$92.00K		$1.94M
2022-12-31	$3.65M*	$7.12M*	-$4.61M*				-$695.00K*
2022-09-30	$982.00K*	-$5.87M*	$0.00*			$999.00K*
2022-06-30	-$7.01M*	-$63.99M*	-$25.00M*
2022-03-31	$524.00K	$3.05M	-$8.35M					-$4.65M
2021-12-31	$2.61M*	-$195.97M*					$288.57M*
2021-09-30	$8.88M*	-$27.01M*					$2.49M*
2021-06-30	$2.63M*	-$30.91M*					$1.88M*
2021-03-31	-$5.99M	-$215.37M					$271.39M*	$48.62M
2020-12-31	-$9.71M*	-$383.06M*					$266.44M*
2020-09-30	-$4.84M*	$120.34M*					$2.15M*
2020-06-30	-$1.37M*	-$119.05M*					$114.13M*
2020-03-31	$1.06M	-$542.00K					$2.86M*	$3.39M
2019-12-31	$740.88K*	$789.99K*				-$68.81M*	$69.90M*
2019-09-30	-$813.39K*	-$36.65M*				$3.27K*	$1.41M*
2019-06-30	-$1.06M*	-$21.42M*					$70.36M*
2019-03-31	-$189.60K	-$5.65M					$1.29M*	-$4.56M
2018-12-31	-$359.41K*	-$1.10M*				$9.81M*	$15.13M*	$23.48M*
2018-09-30	-$664.23K*	-$10.79M*				$0.00*	$5.30M*	-$6.16M*
2018-06-30	-$1.27M*	-$711.36K*				$0.00*	$2.99M*	$1.02M*
2018-03-31	-$1.06M	-$284.89K				$0.00	$5.30M*	$3.95M
2017-12-31	-$1.22M*	-$519.37K*				-$11.41M*	$12.79M*	-$355.32K*
2017-09-30	-$965.01K*	-$234.16K*				$0.00*	$3.74M*	$2.54M*
2017-06-30	-$568.17K*	-$405.77K*				-$165.99K*	-$538.40K*	-$1.68M*
2017-03-31	-$829.92K	-$641.28K				$11.57M		$10.01M
2016-12-31	-$765.50K*	-$396.47K*				$0.00*	$3.13M*
2016-09-30	-$1.53M*	-$72.34K*				$0.00*
2016-06-30	-$1.45M	-$193.86K				$0.00	$3.38M*
2016-03-31	-$1.97M	-$405.26K				$0.00
2015-12-31	-$1.39M*	-$378.59K*				$2.04M*
2015-09-30	-$1.07M*	-$225.79K*				$0.00*	$5.97M*
2015-06-30	-$1.87M	-$109.61K				$3.90M	-$932.04K*
2015-03-31	-$1.29M*	-$2.28K*					$1.93M*
2014-12-31	-$1.06M*	$0.00*					$1.73M*
2014-09-30	-$857.53K*	-$67.85K*					$858.22K*
2014-06-30	$917.00K	$0.00					$717.97K*	-$199.08K
2014-03-31	-$1.22M*	$655.00*					$1.37M*	$149.61K*
2013-12-31	-$841.58K*	-$2.04K*					$531.12K*	-$312.50K*
2013-09-30	-$1.15M*	-$6.24K*					$1.46M*	$304.94K*
2013-06-30	-$1.17M	-$131.26K					$966.68K*	-$335.57K
2013-03-31	-$1.11M*	-$107.52K*					$1.19M*	-$22.00K*
2012-12-31	-$1.02M*	-$24.39K*						-$1.08M*
2012-09-30	-$1.23M*	-$2.91K*						-$1.30M*
2012-06-30	-$1.42M	-$43.87K						-$1.65M
2012-03-31	-$2.11M*	-$18.99K*			$0.00*		$3.95M*	$1.82M*
2011-12-31	-$1.48M*	-$166.72K*			$0.00*		-$508.50K*	-$2.16M*
2011-09-30	-$1.64M*	-$132.54K*						-$2.10M*
2011-06-30	-$1.55M	-$69.81K					-$605.40K*	-$2.22M
2011-03-31	-$1.17M*	-$70.90K*					$7.81M*	$6.57M*
2010-12-31	-$1.41M*	-$49.52K*						-$1.03M*
2010-09-30	-$985.03K*	-$89.79K*					$2.72M*	$1.65M*
2010-06-30	-$1.25M	-$255.23K						-$1.53M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Theravance Biopharma, Inc. (TBPH)		$0.885B	16.40
RIGEL PHARMACEUTICALS INC (RIGL)	United States	$0.893B	2.25
Apnimed, Inc. (APMD)	United States	$0.899B
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
Jade Biosciences, Inc. (JBIO)	United States	$0.936B	-9.21
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
GYRE THERAPEUTICS, INC. (GYRE)	United States	$0.818B	-24.71